University of Pennsylvania School of Engineering and Applied Science Oct 1 2024 Penn Engineers have discovered a novel means of directing lipid nanoparticles (LNPs), the revolutionary molecules that delivered the COVID-19 vaccines, to target specific tissues, presaging a new era in personalized medicine and gene therapy .  While past research -; including at Penn Engineering -; has screened "libraries" of LNPs to find specific variants that target organs like the lungs, this approach is akin to

Tag-uri: Coronavirus